Cargando…
Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6
Glycogen synthase kinase-3 (GSK-3) is a key regulator of many cellular signaling pathways. Unlike most kinases, GSK-3 is controlled by inhibition rather than by specific activation. In the insulin and several other signaling pathways, phosphorylation of a serine present in a conserved sequence near...
Autores principales: | Stamos, Jennifer L, Chu, Matthew Ling-Hon, Enos, Michael D, Shah, Niket, Weis, William I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953950/ https://www.ncbi.nlm.nih.gov/pubmed/24642411 http://dx.doi.org/10.7554/eLife.01998 |
Ejemplares similares
-
Direct Inhibition of GSK3β by the Phosphorylated Cytoplasmic Domain of LRP6 in Wnt/β-Catenin Signaling
por: Piao, Shunfu, et al.
Publicado: (2008) -
FAK/PYK2 promotes the Wnt/β-catenin pathway and intestinal tumorigenesis by phosphorylating GSK3β
por: Gao, Chenxi, et al.
Publicado: (2015) -
Inhibition of GSK3 Phosphorylation of β-Catenin via Phosphorylated PPPSPXS Motifs of Wnt Coreceptor LRP6
por: Wu, Geng, et al.
Publicado: (2009) -
G Protein-coupled Receptor Kinases Phosphorylate LRP6 in the Wnt Pathway
por: Chen, Minyong, et al.
Publicado: (2009) -
LRP5 and LRP6 in Wnt Signaling: Similarity and Divergence
por: Ren, Qian, et al.
Publicado: (2021)